NCT03966872 Comparative Effectiveness of IIMR Versus CDSMP
| NCT ID | NCT03966872 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dartmouth-Hitchcock Medical Center |
| Condition | Mental Illness |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2019-09-02 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2019-09-02 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will enroll 600 people with serious mental illness who receive services at Centerstone in KY or TN and will compare two different evidence-based self-management interventions: Integrated Illness Management and Recovery (I-IMR), a program developed by the study team at Dartmouth that trains people with serious mental illness on physical and mental health self-management, and the Stanford Chronic Disease Self-Management Program (CDSMP), a program largely focused on physical health self-management that has been used widely in the general population.
Eligibility Criteria
Inclusion Criteria: * Serious Mental Illness (diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or chronic depression with moderate impairment in functioning) receiving services at Centerstone(KY and TN) * Diagnosis of a chronic medical condition increasing risk of early mortality from cardiovascular or respiratory disease (e.g., diabetes, hyperlipidemia, hypertension, COPD, heart failure, tobacco dependence, obesity), and at least 1 ER visit or hospitalization within the past year or judgment by the treatment team of substantial need for illness self-management training. Exclusion Criteria: * Consumers who do not speak English * Consumers with either no, or a well-controlled medical condition will not be included * Individuals residing in a nursing home or other institution * Evidence of significant cognitive impairment as indicated by a Mini Mental Status Examination score \<24, will be excluded Eligibility for the COVID -related substudy is dependent on enrollment and participation in the parent project.
Contact & Investigator
Sarah Pratt
PRINCIPAL INVESTIGATOR
Dartmouth-Hitchcock Medical Center
Frequently Asked Questions
Who can join the NCT03966872 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Mental Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03966872 currently recruiting?
Yes, NCT03966872 is actively recruiting participants. Contact the research team at Meghan.M.Santos@Dartmouth.edu for enrollment information.
Where is the NCT03966872 trial being conducted?
This trial is being conducted at Louisville, United States, Nashville, United States.
Who is sponsoring the NCT03966872 clinical trial?
NCT03966872 is sponsored by Dartmouth-Hitchcock Medical Center. The principal investigator is Sarah Pratt at Dartmouth-Hitchcock Medical Center. The trial plans to enroll 600 participants.